Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. CHO (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), N. Kang (Seoul, Republic of Korea), Y. Im (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), D. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), J. Jung (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea). Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials. 2004

Member's Comments

No comment yet.

Related content which might interest you: Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Interval Exercise Training in Poorly Controlled Asthma: Preliminary Clinical Trial Results Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Assessing the Need for Adenotonsillectomy for Sleep-Disordered Breathing in a Community Setting.A Randomized Controlled Study. Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019 Year: 2019 LATE-BREAKING ABSTRACT: TITLE: Hypertonic Saline in Acute Bronchiolitis: Randomised Controlled Trial (RCT) and Economic Evaluation (The SABRE Study) Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014 Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients. Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2) Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020 Individualised Respiratory Physiology-oriented High-intensity Non-invasive Positive Pressure Ventilation in Stable Hypercapnic COPD Patients: a Prospective, Randomized, Controlled Trial Source: International Congress 2019 – Current trends in noninvasive ventilation for chronic respiratory failure Year: 2019 Book Review: Scleroderma: From Pathogenesis to Comprehensive Management Source: Eur Respir Rev 2012 21: 371 Year: 2012 The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration Source: Breathe, 13 (3) 180; 10.1183/20734735.005117 Year: 2017